ALNYLAM PHARMACE.DL-,0001 earnings per share and revenue

DUL earnings per share for the last quarter are -1.00 EUR whereas the estimation was -1.07 EUR which accounts for 7.28% surprise. Company revenue for the same period amounts to 398.39 M EUR despite the estimated figure of 395.85 M EUR. Estimated earnings per share for the next quarter are -1.03 EUR, and revenue is expected to reach 396.67 M EUR. Also watch annual changes over time to get a bigger picture of DUL earnings per share and revenue dynamics.